Maternal & Child Health Research Institute (MCHRI)
Showing 141-150 of 215 Results
-
Emily Scarpulla Raymond
Member, Maternal & Child Health Research Institute (MCHRI)
BioDr. Emily Scarpulla Raymond, PhD is a pediatric psychology fellow at Stanford University. She received her PhD at the University of Maine, Orono in clinical psychology in 2024 and received her bachelor’s degree in psychology at the University of Rochester in 2018. Emily has conducted research focusing on adolescent psychosocial behavior and outcomes with a particular emphasis on the role of social media in adolescent friendships. As a clinician, Emily works with children and adolescents with comorbid medical and psychological conditions in several medical clinics through Lucile Packard Children's Hospital Stanford.
-
Eduardo Pontes Reis
Affiliate, Rad/Pediatric Radiology
BioI'm a visiting scholar at Stanford AIMI Center, working in the intersection of Artificial Intelligence and Medicine. My purpose is to contribute to our understanding of intelligence. And our best chance to achieve this is through AI.
Research highlights:
- Published BRAX, the Brazilian Chest X-ray Dataset - https://www.nature.com/articles/s41597-022-01608-8
- Open-sourced the PyTorch implementation of ConVIRT (Y Zhang et al), a contrastive learning method for radiologic images and text (before CLIP) - https://github.com/edreisMD/ConVIRT-pytorch
- Released Brain Hemorrhage Annotations - Brain Hemorrhage Extended - BHX (https://physionet.org/content/bhx-brain-bounding-box)
At Hospital Israelita Albert Einstein:
- Started the Health Story project, a medical history timeline to support research and a more personalized clinical practice
- Ran the development of AI algorithms for diseases of national importance: Tuberculosis, COVID, Melanoma and Head CT -
Neetu Saini
Postdoctoral Scholar, Stem Cell Transplantation
BioMy research interests focus on translational human T-cell immunology, with an emphasis on regulatory T cells (Tregs) and their therapeutic potential in restoring immune tolerance and tissue homeostasis. I am particularly interested in engineering FOXP3-programmed CD4⁺ T cells as a stable and functional alternative to conventional Tregs, especially in inflammatory settings where endogenous Tregs may be unstable or dysfunctional. My work integrates gene-editing approaches, immunophenotyping, and human organoid systems to study how these engineered cells interact with epithelial and stem cell compartments, with a focus on mechanisms of tissue repair and immune–epithelial crosstalk in barrier tissues such as the intestine. Moving forward, I aim to advance next-generation cell therapies by combining insights from T-cell biology, tissue biology, and disease modeling to develop durable and clinically relevant strategies for treating immune-mediated and epithelial barrier disorders.
